The NMB (Neuromuscular Blockade) is the most frequent complication in anesthesiology associated with an increase in adverse respiratory events in the postoperative period. Its appearance depends on multiple factors. The introduction of a comprehensive educational strategy aimed at promoting the proper management of NMB in the intraoperative period and a package of measures that must be performed (intraoperative neuromuscular monitoring and reversal of the effect of neuromuscular blockers) may contribute to a decrease in the incidence of NMB, Increase safety in the surgical patient and decrease associated costs.
Multicenter, epidemiological, prospective, randomized, sequential study. The introduction of an educational program and a package of clinical measures (specific monitoring and pharmacological reversion) in the incidence of NMB will be evaluated by evaluating variations in this incidence of NMB, the rate of compliance with the preventive measures and the perception of the Safety in the perioperative, through pre and postoperative survey.
Study Type
OBSERVATIONAL
Enrollment
2,314
Intraoperative neuromuscular monitoring and pharmacological reversion of NMB according to data sheet
Hospital la Fe
Valencia, Spain
Incidence of PORC.
To reduce the incidence of PORC ≤ 10% by the introduction of an educational program and a bundle of preventive measures (including intraoperative monitoring and reversal of neuromuscular blocking agents (NMBA)).
Time frame: Six months, first three months to evaluate PORC incidence and then three months to evaluate PORC incidence after educational intervention.
Compliance rate with the bundle of measures
To evaluate if the educational program increases compliance of clinical preventive measures, if the reduction of incidence of BNMR is maintained, and, in addition, if this compliance is maintained over time.
Time frame: Six months, first three months to evaluate PORC incidence and then three months to evaluate PORC incidence after educational intervention.
Rate of intraoperative monitoring
Rate of compliance of clinical prevention measures with intraoperative monitoring.
Time frame: Six months, from the beginning, with no intervention, until the end of phase III (end of recruitment in both groups).
Rate of reversal of NMBA
Rate of compliance of clinical prevention measures with NMBA reversal after surgery.
Time frame: Six months, from the beginning, with no intervention, until the end of phase III (end of recruitment in both groups).
Perception of safety -increase- by anesthesiologists
To evaluate, from the point of view of patient safety, whether the perception of safety by clinicians is maintained, through a survey before and after the intervention.
Time frame: Six months, from the beginning, with no intervention, until the end of phase III (end of recruitment in both groups).
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Incidence of postoperative adverse events.
Incidence of postoperative complications in relation to the NMB reversal rate.
Time frame: Six months, from the beginning, with no intervention, until the end of phase III (end of recruitment in both groups).